Stock 8049 JILIN PROVINCE HUINAN CHANGLONG BIO-PHARMACY COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Equities

8049

CNE100000130

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-16 am EDT 		5-day change 1st Jan Change
1.81 HKD 0.00% Intraday chart for Jilin Province Huinan Changlong Bio-pharmacy Company Limited +7.74% +10.37%
Mar. 28 Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Approves Special Dividend, Payment Date 30 June 2023
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Declares and Proposes a Special Dividend, Payable on or Before 30 June 2023
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Approves Special Dividend, Payable on or Before 31 August 2022
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Proposes Special Dividend, Payable on or Before 31 August 2022
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Approves Appointment of Bai Jun Gui as an Independent Non-Executive Director, Member of the Audit and Remuneration and Nomination Committee
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Announces Special Dividend , Payable on November 18, 2021
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Proposes Special Dividend
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Announces Resignation of Gao Yong Cai as Independent Non-Executive Director
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Recommends Special Dividend, Payable on or Before November 18, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8049 Stock
  4. News Jilin Province Huinan Changlong Bio-pharmacy Company Limited